43 results on '"E. Asano"'
Search Results
2. Budget Impact Analysis of Ustekinumab for the Treatment of Moderate to Severe Crohn’s Disease from a Brazilian Private Payer Perspective
3. Use of A Multi-Decision Criteria Analysis to Support Healthcare Decision-Making for Private Payers in Brazil: Development of a Model To Guide Reimbursement Decisions
4. COST-MINIMIZATION ANALYSES OF BIOLOGICAL THERAPIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS UNDER THE BRAZILIAN PUBLIC HEALTH SYSTEM PERSPECTIVE
5. Treatment Sequencing for Patients With Multiple Myeloma with at Least One Prior Line: Comparing Progression-Free Survival and Costs Under a Private Payer Perspective
6. Análise De Custo Efetividade Da Toxina Onabotulínica A No Tratamento Preventivo Da Migrânea Crônica
7. Treatment Patterns and Costs Associated with Chronic Lymphocytic Leukemia Chemotherapy Under the Brazilian Private Health Care Perspective: A Retrospective Analysis of the Orizon Database
8. Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Public Health Care System in Brazil: Results from a Retrospective Analysis of an Administrative Database
9. Treatment Patterns And Health Care Utilization Of Prostate Cancer In Brazil: Results From A Physician Survey
10. Budget Impact Analysis Of The Introduction Of Darunavir 800 Mg Qd For The 2nd Line Treatment Of Hiv-Infected Treatment-Experienced Adults On The Brazilian National Hiv Program
11. BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
12. BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR NAÏVE PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
13. Direct Medical Costs of Treating Chronic Lymphocytic Leukemia Patients in the Private Healthcare System in Brazil: Results From A 24-Month Retrospective Analysis of an Administrative Database
14. COST-MINIMIZATION ANALYSIS OF BIOLOGICAL DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS UNDER THE BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE
15. COST-MINIMIZATION ANALYSIS OF TNF INHIBITORS IN THE TREATMENT OF SPONDYLOARTHRITIS (PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS) UNDER THE BRAZILIAN PUBLIC HEALTH SYSTEM PERSPECTIVE
16. BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
17. Budget Impact Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Cancer Patients Under the Brazilian Private Health Care System Perspective
18. Cost Effectiveness of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Cancer Patients Under the Brazilian Private Health Care System Perspective
19. Budget Impact Analysis of the Incorporation of Ibrutinib for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia in the Brazilian Private Health Care System
20. BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
21. COST-MINIMIZATION ANALYSIS OF BIOLOGICAL DRUGS IN THE TREATMENT OF SPONDYLOARTHRITIS (PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS) UNDER THE BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE
22. Incidence Rates Of Patients Starting Treatment For Chronic Lymphocytic Leukemia In The Brazilian Public Health Care System: A Retrospective Epidemiologic Study Based On Datasus
23. PUK10 KIT73 STUDY: RELATIONSHIP BETWEEN COSTS OF CARE AND 12-MONTH GLOMERULAR FILTRATION RATES IN POST-KIDNEY TRANSPLANT PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)
24. PCN125 MELODY BRASIL: TREATMENT PATTERNS AND ASSOCIATED COSTS OF METASTATIC MELANOMA PATIENTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM (SUS)
25. PUK7 IMMUNOSUPPRESSANT THERAPY PATTERNS AND ITS COSTS IN POST KIDNEY TRANSPLANT PATIENTS IN THE NATIONAL TRANSPLANT PROGRAM IN BRAZIL
26. PUK21 POST-KIDNEY TRANSPLANT MORBIDITY RELATED RE-HOSPITALIZATIONS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM: CAUSES, RESOURCES USE AND COSTS BASED ON AN ADMINISTRATIVE REGISTRY REVIEW FROM 2004 TO 2009
27. PCN34 BUDGET IMPACT ANALYSIS OF DASATINIB IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) IN BRAZIL
28. Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Add-On To Metformin Plus Sulfonylurea In Patients With Type 2 Diabetes Mellitus (T2dm) In Brazil
29. Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil: Results from a 12-Month Retrospective Analysis of an Administrative Database
30. PSU29 The Importance of Medical Appointments After Roux-en-Y Gastric Bypass in Morbid Obese Patients: Association Between Adherence to Medical Follow-Up Visits and the Bariatric Analysis and Reporting Outcome System (BAROS) Score Based on an Administrative Database (DATASUS) in Brazil
31. PCN79 IMPACT OF NON-ADHERENCE TO IMATINIB ON PROGRESSION-FREE SURVIVAL AS 1ST TREATMENT FOR CHRONIC MYELOID LEUKEMIA IN BRAZIL: TWO YEARS FOLLOW UP
32. PUK19 KIT73: PRELIMINARY REPORTS OF IMMUNOSUPRESSANT THERAPY PATTERNS IN A COHORT OF POST KIDNEY TRANSPLANT PATIENTS IN BRAZIL
33. Total Treatment Costs Analysis Between Subcutaneous and Intravenous Bortezomib Under Brazilian Private Health Care System Perspective
34. PDB13 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 (T2D) PATIENTS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
35. PCN124 COST-UTILITY ANALYSIS OF DASATINIB IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) ON CHRONIC (CP), ACCELERATED (AP) AND BLAST (BP) PHASES IN BRAZIL
36. Treatment Patterns of Chronic Lymphocytic Leukemia Patients Under the Brazilian Public Health Care Perspective
37. Budget Impact Analysis of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated with Docetaxel from the Perspective of the Brazilian Private Health Care System
38. Treatment Patterns of Indolent Non-Hodgkin Lymphoma Patients Under the Brazilian Public Health Care Perspective
39. PCN122 MELODY BRAZIL: CHEMOTHERAPY CHOICES FOR PATIENTS WITH METASTATIC MELANOMA IN THE PUBLIC HEALTH CARE SYSTEM (SUS)
40. PDB62 COST-UTILITY ANALYSIS OF SAXAGLIPTIN AS AN ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES PATIENTS FROM THE BRAZILIAN PRIVATE HEALTH SYSTEM
41. PDB14 HOSPITALIZATION ATTRIBUTED TO DIABETES MELLITUS AND ITS COMPLICATIONS IN THE PRIVATE HEALTH-CARE SYSTEM IN RIBEIRÃO PRETO REGION, BRAZIL
42. PUK22 REJECTION EPISODES REQUIRING HOSPITALIZATION AFTER KIDNEY TRANSPLANT IN BRAZIL: A RETROSPECTIVE DATABASE STUDY OF THE BRAZILIAN PUBLIC HEALTH SYSTEM
43. PSU28 Variables Associated with Length of Stay and ICU Need in Roux-en-Y Gastric Bypass Surgery for Morbid Obese Patients: A Cross-Sectional Study Based on the Public Health System Database (DATASUS) in Brazil
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.